Skip to main content
Canna~Fangled Abstracts

Endocannabinoid system in trauma and psychosis: distant guardian of mental stability

By March 1, 2021March 3rd, 2021No Comments
We describe the role of the endocannabinoid system in the cannabinoid self-medication-theory and extinction learning.

doi: 10.1515/revneuro-2020-0102.

Online ahead of print.
Affiliations 

Abstract

Central endocannabinoid system (eCBS) is a neuromodulatory system that inhibits potentially harmful, excessive synaptic activation. Endocannabinoid receptors are abundant among brain structures pivotal in different mental disorders development (for example, hippocampus, amygdala, medial-prefrontal cortex, hypothalamus). Here, we review eCBS function in etiology of psychosis, emphasizing its role in dealing with environmental pressures such as traumatic life events. Moreover, we explore eCBS as a guard against hypothalamic-pituitary-adrenal axis over-activation, and discuss its possible role in etiology of different psychopathologies. Additionally, we review eCBS function in creating adaptive behavioral patterns, as we explore its involvement in the memory formation process, extinction learning and emotional response. We discuss eCBS in the context of possible biomarkers of trauma, and in preclinical psychiatric conditions, such as at-risk mental states and clinical high risk states for psychosis. Finally, we describe the role of eCBS in the cannabinoid self-medication-theory and extinction learning.

 

Keywords: HPA, biomarkers, endocannabinoid system, psychosis, trauma

References

    1. Aas, M., Pizzagalli, D.A., Laskemoen, J.F., Reponen, E.J., Ueland, T., Melle, I., and Andreassen, O.A. (2019). Elevated hair cortisol is associated with childhood maltreatment and cognitive impairment in schizophrenia and in bipolar disorders. Schizophr. Res. 213: 65–71, https://doi.org/10.1016/j.schres.2019.01.011.
    1. Addington, J., Cornblatt, B.A., Cadenhead, K.S., Cannon, T.D., McGlashan, T.H., Perkins, D.O., and Heinssen, R. (2011). At clinical high risk for psychosis: outcome for nonconverters. Am. J. Psychiatry 168: 800–805, https://doi.org/10.1176/appi.ajp.2011.10081191.
    1. Adriano, F., Caltagirone, C., and Spalletta, G. (2012). Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist 18: 180–200, https://doi.org/10.1177/1073858410395147.
    1. Allan, S.M., Hodgekins, J., Beazley, P., and Oduola, S. (2020). Pathways to care in at‐risk mental states: a systematic review. Early Interv. Psychiatry, https://doi.org/10.1111/eip.13053.
    1. Althwanay, A., AlZamil, N.A., Almukhadhib, O.Y., Alkhunaizi, S., and Althwanay, R. (2020). Risks and protective factors of the prodromal stage of psychosis: a literature review. Cureus 12.

Leave a Reply